© Copyright 2019 Pharmaceutics International, Inc. | Privacy Policy | Terms & Conditions

Formulation Capabilities

Pii operates over 360,000 square feet of state-of-the-art pharmaceutical development and manufacturing space, all located on one campus in Hunt Valley, MD.  This includes over 70 flexible, manufacturing suites, several with the required containment controls for handling potent compounds and hormones, as well as a dedicated suite for the production of soft gel capsules.  Licensed to manufacture DEA Schedule I-V products, with capabilities for both oral delivery and parenteral dosage forms, Pii has the depth to support development, clinical and commercial requirements.  Facilities are cGMP qualified and include dedicated formulation development centers for solid oral, liquid and sterile products. 

Potent Compounds


DEA Schedule I-V



Bioavailability Enhancement


Bioavailability Enhancement

Bioavailability Enhancement

First-in-Man Phase I